Development and validation of a new tool to assess the Burden of Sensitive Skin (BoSS).
Identifieur interne : 000983 ( Main/Exploration ); précédent : 000982; suivant : 000984Development and validation of a new tool to assess the Burden of Sensitive Skin (BoSS).
Auteurs : L. Misery [France] ; E. Jourdan [France] ; S. Abadie [France] ; K. Ezzedine [France] ; E. Brenaut [France] ; F. Huet [France] ; M. Sayag [France] ; C. Taieb [France]Source :
- Journal of the European Academy of Dermatology and Venereology : JEADV [ 1468-3083 ] ; 2018.
Descripteurs français
- KwdFr :
- MESH :
- psychologie : Maladies de la peau.
- complications : Adulte, Coûts indirects de la maladie, Enquêtes et questionnaires, Femelle, Humains, Maladies de la peau, Mâle, Psychométrie, Qualité de vie, Reproductibilité des résultats.
English descriptors
- KwdEn :
- MESH :
- complications : Skin Diseases.
- psychology : Skin Diseases.
- Adult, Cost of Illness, Female, Humans, Male, Psychometrics, Quality of Life, Reproducibility of Results, Surveys and Questionnaires.
Abstract
BACKGROUND
Sensitive skin usually manifests itself as unpleasant sensations and sometimes erythema. There are various triggering factors for this condition. Although sensitive skin may alter quality of life, its burden has not yet been explored.
OBJECTIVE
The aim of this study was to develop and validate a specific sensitive skin burden questionnaire called the BoSS (Burden of Sensitive Skin).
METHODS
A conceptual phase was developed, followed by a development phase, external validation, psychometric analysis, test-retest analysis and, finally, a translation, cross-cultural adaptation and cognitive debriefing.
RESULTS
A total of 6471 individuals participated in the study (4614 people in the validation study). The dimensionality of items was evaluated using factor analyses, suggesting three dimensions (self-care, daily life and appearance). Unidimensionality was confirmed by higher order factor analysis. The overall Cronbach's α coefficient was high, and intradimensional coherences all demonstrated good reliability. The final instrument consisted of 14 items. The test-retest reliability demonstrated very good reproducibility. The intraclass correlation of each dimension was high. External validity was confirmed by the correlation coefficients of the BoSS vs. those of the SF-12 and the DLQI assessment tools.
CONCLUSION
BoSS is the first reliable tool to assess the burden of sensitive skin.
DOI: 10.1111/jdv.15186
PubMed: 30022546
Affiliations:
- France
- Auvergne-Rhône-Alpes, Rhône-Alpes, Région Bretagne, Île-de-France
- Brest, Créteil, Lyon, Paris
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Development and validation of a new tool to assess the Burden of Sensitive Skin (BoSS).</title><author><name sortKey="Misery, L" sort="Misery, L" uniqKey="Misery L" first="L" last="Misery">L. Misery</name><affiliation wicri:level="3"><nlm:affiliation>Department of Dermatology, University Hospital of Brest, Brest, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Dermatology, University Hospital of Brest, Brest</wicri:regionArea><placeName><region type="region">Région Bretagne</region><region type="old region">Région Bretagne</region><settlement type="city">Brest</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Laboratory on Interactions Neurons-Keratinocytes (LINK), University of Western Brittany, Brest, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratory on Interactions Neurons-Keratinocytes (LINK), University of Western Brittany, Brest</wicri:regionArea><placeName><region type="region">Région Bretagne</region><region type="old region">Région Bretagne</region><settlement type="city">Brest</settlement></placeName></affiliation></author><author><name sortKey="Jourdan, E" sort="Jourdan, E" uniqKey="Jourdan E" first="E" last="Jourdan">E. Jourdan</name><affiliation wicri:level="3"><nlm:affiliation>Bioderma (Naos Group), Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Bioderma (Naos Group), Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Abadie, S" sort="Abadie, S" uniqKey="Abadie S" first="S" last="Abadie">S. Abadie</name><affiliation wicri:level="3"><nlm:affiliation>Qualees, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Qualees, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Ezzedine, K" sort="Ezzedine, K" uniqKey="Ezzedine K" first="K" last="Ezzedine">K. Ezzedine</name><affiliation wicri:level="3"><nlm:affiliation>Department of Dermatology, Henri Mondor Hospital, Créteil, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Dermatology, Henri Mondor Hospital, Créteil</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Créteil</settlement></placeName></affiliation></author><author><name sortKey="Brenaut, E" sort="Brenaut, E" uniqKey="Brenaut E" first="E" last="Brenaut">E. Brenaut</name><affiliation wicri:level="3"><nlm:affiliation>Department of Dermatology, University Hospital of Brest, Brest, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Dermatology, University Hospital of Brest, Brest</wicri:regionArea><placeName><region type="region">Région Bretagne</region><region type="old region">Région Bretagne</region><settlement type="city">Brest</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Laboratory on Interactions Neurons-Keratinocytes (LINK), University of Western Brittany, Brest, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratory on Interactions Neurons-Keratinocytes (LINK), University of Western Brittany, Brest</wicri:regionArea><placeName><region type="region">Région Bretagne</region><region type="old region">Région Bretagne</region><settlement type="city">Brest</settlement></placeName></affiliation></author><author><name sortKey="Huet, F" sort="Huet, F" uniqKey="Huet F" first="F" last="Huet">F. Huet</name><affiliation wicri:level="3"><nlm:affiliation>Department of Dermatology, University Hospital of Brest, Brest, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Dermatology, University Hospital of Brest, Brest</wicri:regionArea><placeName><region type="region">Région Bretagne</region><region type="old region">Région Bretagne</region><settlement type="city">Brest</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Laboratory on Interactions Neurons-Keratinocytes (LINK), University of Western Brittany, Brest, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratory on Interactions Neurons-Keratinocytes (LINK), University of Western Brittany, Brest</wicri:regionArea><placeName><region type="region">Région Bretagne</region><region type="old region">Région Bretagne</region><settlement type="city">Brest</settlement></placeName></affiliation></author><author><name sortKey="Sayag, M" sort="Sayag, M" uniqKey="Sayag M" first="M" last="Sayag">M. Sayag</name><affiliation wicri:level="3"><nlm:affiliation>Bioderma (Naos Group), Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Bioderma (Naos Group), Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Taieb, C" sort="Taieb, C" uniqKey="Taieb C" first="C" last="Taieb">C. Taieb</name><affiliation wicri:level="1"><nlm:affiliation>EMMA, Fontenay-aux-Roses, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>EMMA, Fontenay-aux-Roses</wicri:regionArea><wicri:noRegion>Fontenay-aux-Roses</wicri:noRegion><wicri:noRegion>Fontenay-aux-Roses</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:30022546</idno><idno type="pmid">30022546</idno><idno type="doi">10.1111/jdv.15186</idno><idno type="wicri:Area/Main/Corpus">000771</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000771</idno><idno type="wicri:Area/Main/Curation">000771</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000771</idno><idno type="wicri:Area/Main/Exploration">000771</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Development and validation of a new tool to assess the Burden of Sensitive Skin (BoSS).</title><author><name sortKey="Misery, L" sort="Misery, L" uniqKey="Misery L" first="L" last="Misery">L. Misery</name><affiliation wicri:level="3"><nlm:affiliation>Department of Dermatology, University Hospital of Brest, Brest, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Dermatology, University Hospital of Brest, Brest</wicri:regionArea><placeName><region type="region">Région Bretagne</region><region type="old region">Région Bretagne</region><settlement type="city">Brest</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Laboratory on Interactions Neurons-Keratinocytes (LINK), University of Western Brittany, Brest, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratory on Interactions Neurons-Keratinocytes (LINK), University of Western Brittany, Brest</wicri:regionArea><placeName><region type="region">Région Bretagne</region><region type="old region">Région Bretagne</region><settlement type="city">Brest</settlement></placeName></affiliation></author><author><name sortKey="Jourdan, E" sort="Jourdan, E" uniqKey="Jourdan E" first="E" last="Jourdan">E. Jourdan</name><affiliation wicri:level="3"><nlm:affiliation>Bioderma (Naos Group), Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Bioderma (Naos Group), Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Abadie, S" sort="Abadie, S" uniqKey="Abadie S" first="S" last="Abadie">S. Abadie</name><affiliation wicri:level="3"><nlm:affiliation>Qualees, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Qualees, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Ezzedine, K" sort="Ezzedine, K" uniqKey="Ezzedine K" first="K" last="Ezzedine">K. Ezzedine</name><affiliation wicri:level="3"><nlm:affiliation>Department of Dermatology, Henri Mondor Hospital, Créteil, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Dermatology, Henri Mondor Hospital, Créteil</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Créteil</settlement></placeName></affiliation></author><author><name sortKey="Brenaut, E" sort="Brenaut, E" uniqKey="Brenaut E" first="E" last="Brenaut">E. Brenaut</name><affiliation wicri:level="3"><nlm:affiliation>Department of Dermatology, University Hospital of Brest, Brest, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Dermatology, University Hospital of Brest, Brest</wicri:regionArea><placeName><region type="region">Région Bretagne</region><region type="old region">Région Bretagne</region><settlement type="city">Brest</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Laboratory on Interactions Neurons-Keratinocytes (LINK), University of Western Brittany, Brest, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratory on Interactions Neurons-Keratinocytes (LINK), University of Western Brittany, Brest</wicri:regionArea><placeName><region type="region">Région Bretagne</region><region type="old region">Région Bretagne</region><settlement type="city">Brest</settlement></placeName></affiliation></author><author><name sortKey="Huet, F" sort="Huet, F" uniqKey="Huet F" first="F" last="Huet">F. Huet</name><affiliation wicri:level="3"><nlm:affiliation>Department of Dermatology, University Hospital of Brest, Brest, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Dermatology, University Hospital of Brest, Brest</wicri:regionArea><placeName><region type="region">Région Bretagne</region><region type="old region">Région Bretagne</region><settlement type="city">Brest</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Laboratory on Interactions Neurons-Keratinocytes (LINK), University of Western Brittany, Brest, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratory on Interactions Neurons-Keratinocytes (LINK), University of Western Brittany, Brest</wicri:regionArea><placeName><region type="region">Région Bretagne</region><region type="old region">Région Bretagne</region><settlement type="city">Brest</settlement></placeName></affiliation></author><author><name sortKey="Sayag, M" sort="Sayag, M" uniqKey="Sayag M" first="M" last="Sayag">M. Sayag</name><affiliation wicri:level="3"><nlm:affiliation>Bioderma (Naos Group), Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Bioderma (Naos Group), Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Taieb, C" sort="Taieb, C" uniqKey="Taieb C" first="C" last="Taieb">C. Taieb</name><affiliation wicri:level="1"><nlm:affiliation>EMMA, Fontenay-aux-Roses, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>EMMA, Fontenay-aux-Roses</wicri:regionArea><wicri:noRegion>Fontenay-aux-Roses</wicri:noRegion><wicri:noRegion>Fontenay-aux-Roses</wicri:noRegion></affiliation></author></analytic><series><title level="j">Journal of the European Academy of Dermatology and Venereology : JEADV</title><idno type="eISSN">1468-3083</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Cost of Illness (MeSH)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Psychometrics (MeSH)</term><term>Quality of Life (MeSH)</term><term>Reproducibility of Results (MeSH)</term><term>Skin Diseases (complications)</term><term>Skin Diseases (psychology)</term><term>Surveys and Questionnaires (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Coûts indirects de la maladie (MeSH)</term><term>Enquêtes et questionnaires (MeSH)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Maladies de la peau (complications)</term><term>Maladies de la peau (psychologie)</term><term>Mâle (MeSH)</term><term>Psychométrie (MeSH)</term><term>Qualité de vie (MeSH)</term><term>Reproductibilité des résultats (MeSH)</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Skin Diseases</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Maladies de la peau</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Skin Diseases</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Cost of Illness</term><term>Female</term><term>Humans</term><term>Male</term><term>Psychometrics</term><term>Quality of Life</term><term>Reproducibility of Results</term><term>Surveys and Questionnaires</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="fr"><term>Adulte</term><term>Coûts indirects de la maladie</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Humains</term><term>Maladies de la peau</term><term>Mâle</term><term>Psychométrie</term><term>Qualité de vie</term><term>Reproductibilité des résultats</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Sensitive skin usually manifests itself as unpleasant sensations and sometimes erythema. There are various triggering factors for this condition. Although sensitive skin may alter quality of life, its burden has not yet been explored.</p></div><div type="abstract" xml:lang="en"><p><b>OBJECTIVE</b></p><p>The aim of this study was to develop and validate a specific sensitive skin burden questionnaire called the BoSS (Burden of Sensitive Skin).</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>A conceptual phase was developed, followed by a development phase, external validation, psychometric analysis, test-retest analysis and, finally, a translation, cross-cultural adaptation and cognitive debriefing.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>A total of 6471 individuals participated in the study (4614 people in the validation study). The dimensionality of items was evaluated using factor analyses, suggesting three dimensions (self-care, daily life and appearance). Unidimensionality was confirmed by higher order factor analysis. The overall Cronbach's α coefficient was high, and intradimensional coherences all demonstrated good reliability. The final instrument consisted of 14 items. The test-retest reliability demonstrated very good reproducibility. The intraclass correlation of each dimension was high. External validity was confirmed by the correlation coefficients of the BoSS vs. those of the SF-12 and the DLQI assessment tools.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>BoSS is the first reliable tool to assess the burden of sensitive skin.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30022546</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-3083</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>12</Issue><PubDate><Year>2018</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of the European Academy of Dermatology and Venereology : JEADV</Title><ISOAbbreviation>J Eur Acad Dermatol Venereol</ISOAbbreviation></Journal><ArticleTitle>Development and validation of a new tool to assess the Burden of Sensitive Skin (BoSS).</ArticleTitle><Pagination><MedlinePgn>2217-2223</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jdv.15186</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sensitive skin usually manifests itself as unpleasant sensations and sometimes erythema. There are various triggering factors for this condition. Although sensitive skin may alter quality of life, its burden has not yet been explored.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to develop and validate a specific sensitive skin burden questionnaire called the BoSS (Burden of Sensitive Skin).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A conceptual phase was developed, followed by a development phase, external validation, psychometric analysis, test-retest analysis and, finally, a translation, cross-cultural adaptation and cognitive debriefing.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 6471 individuals participated in the study (4614 people in the validation study). The dimensionality of items was evaluated using factor analyses, suggesting three dimensions (self-care, daily life and appearance). Unidimensionality was confirmed by higher order factor analysis. The overall Cronbach's α coefficient was high, and intradimensional coherences all demonstrated good reliability. The final instrument consisted of 14 items. The test-retest reliability demonstrated very good reproducibility. The intraclass correlation of each dimension was high. External validity was confirmed by the correlation coefficients of the BoSS vs. those of the SF-12 and the DLQI assessment tools.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">BoSS is the first reliable tool to assess the burden of sensitive skin.</AbstractText><CopyrightInformation>© 2018 European Academy of Dermatology and Venereology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Misery</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University Hospital of Brest, Brest, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory on Interactions Neurons-Keratinocytes (LINK), University of Western Brittany, Brest, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jourdan</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Bioderma (Naos Group), Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abadie</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Qualees, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ezzedine</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Henri Mondor Hospital, Créteil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brenaut</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University Hospital of Brest, Brest, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory on Interactions Neurons-Keratinocytes (LINK), University of Western Brittany, Brest, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huet</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University Hospital of Brest, Brest, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory on Interactions Neurons-Keratinocytes (LINK), University of Western Brittany, Brest, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sayag</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Bioderma (Naos Group), Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taieb</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>EMMA, Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Naos Bioderma</Agency><Country></Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Eur Acad Dermatol Venereol</MedlineTA><NlmUniqueID>9216037</NlmUniqueID><ISSNLinking>0926-9959</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2051-2052</RefSource><PMID Version="1">30488999</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012871" MajorTopicYN="N">Skin Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="Y">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>03</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>07</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30022546</ArticleId><ArticleId IdType="doi">10.1111/jdv.15186</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Auvergne-Rhône-Alpes</li><li>Rhône-Alpes</li><li>Région Bretagne</li><li>Île-de-France</li></region><settlement><li>Brest</li><li>Créteil</li><li>Lyon</li><li>Paris</li></settlement></list><tree><country name="France"><region name="Région Bretagne"><name sortKey="Misery, L" sort="Misery, L" uniqKey="Misery L" first="L" last="Misery">L. Misery</name></region><name sortKey="Abadie, S" sort="Abadie, S" uniqKey="Abadie S" first="S" last="Abadie">S. Abadie</name><name sortKey="Brenaut, E" sort="Brenaut, E" uniqKey="Brenaut E" first="E" last="Brenaut">E. Brenaut</name><name sortKey="Brenaut, E" sort="Brenaut, E" uniqKey="Brenaut E" first="E" last="Brenaut">E. Brenaut</name><name sortKey="Ezzedine, K" sort="Ezzedine, K" uniqKey="Ezzedine K" first="K" last="Ezzedine">K. Ezzedine</name><name sortKey="Huet, F" sort="Huet, F" uniqKey="Huet F" first="F" last="Huet">F. Huet</name><name sortKey="Huet, F" sort="Huet, F" uniqKey="Huet F" first="F" last="Huet">F. Huet</name><name sortKey="Jourdan, E" sort="Jourdan, E" uniqKey="Jourdan E" first="E" last="Jourdan">E. Jourdan</name><name sortKey="Misery, L" sort="Misery, L" uniqKey="Misery L" first="L" last="Misery">L. Misery</name><name sortKey="Sayag, M" sort="Sayag, M" uniqKey="Sayag M" first="M" last="Sayag">M. Sayag</name><name sortKey="Taieb, C" sort="Taieb, C" uniqKey="Taieb C" first="C" last="Taieb">C. Taieb</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000983 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000983 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= AutomedicationFrancoV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:30022546
|texte= Development and validation of a new tool to assess the Burden of Sensitive Skin (BoSS).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:30022546" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AutomedicationFrancoV1
| This area was generated with Dilib version V0.6.38. |  |